All Stories

  1. Inflammation in Cancer: Part of the Problem or Part of the Solution?

    Article • Journal of Immunology Research, February 2019, Hindawi Publishing Corporation

    Donato Zipeto, Iulia Popescu, Professor Monica Neagu

  2. Multiplex assay for multiomics advances in personalized-precision medicine

    Article • Journal of Immunoassay and Immunochemistry, January 2019, Taylor & Francis

    Professor Monica Neagu

  3. Updates in immune-based multiplex assays

    Article • Journal of Immunoassay and Immunochemistry, January 2019, Taylor & Francis

    Professor Monica Neagu

  4. Biomarkers Insights in Psoriasis - Regulatory Cytokines

    Article • Current Biomarkers, June 2018, Bentham Science Publishers

    Professor Monica Neagu

  5. Positioning Europe for the EPITRANSCRIPTOMICS challenge

    Article • RNA Biology, May 2018, Taylor & Francis

    Professor Monica Neagu, Vanessa Zammit

  6. Markers of Oral Lichen Planus Malignant Transformation

    Article • Disease Markers, January 2018, Hindawi Publishing Corporation

    Professor Monica Neagu

  7. Neuroendocrine Factors and Head and Neck Squamous Cell Carcinoma: An Affair to Remember

    Article • Disease Markers, January 2018, Hindawi Publishing Corporation

    Professor Monica Neagu

  8. Innovative array-based assay for omics pattern in melanoma

    Article • Journal of Immunoassay and Immunochemistry, June 2017, Taylor & Francis

    Professor Monica Neagu

  9. Surface-Enhanced Laser Desorption/Ionization Mass Spectrometry for Biomarker Discovery in Cutaneous Melanoma

    Article • Current Proteomics, April 2017, Bentham Science Publishers

    Professor Monica Neagu

  10. Inflammatory Cytokine Pattern Is Sex-Dependent in Mouse Cutaneous Melanoma Experimental Model

    Article • Journal of Immunology Research, January 2017, Hindawi Publishing Corporation

    Professor Monica Neagu

  11. Stem Cells Between Regeneration and Tumorigenesis

    Article • September 2016, Bentham Science Publishers

    Professor Monica Neagu

  12. Immunogenicity of Stem Cell in Tumorigenesis Versus Regeneration

    Article • September 2016, Bentham Science Publishers

    Professor Monica Neagu

  13. Fluorescent Porphyrin with an Increased Uptake in Peripheral Blood Cell Subpopulations from Colon Cancer Patients

    Article • Medicinal Chemistry, April 2015, Bentham Science Publishers

    Professor Monica Neagu

  14. Stem Cells in Pancreatic Cancer

    Article • May 2014, IntechOpen

    Professor Monica Neagu, Dr Ana-Maria Enciu

  15. Increased number of fractionated irradiation sessions does not improve the cellular response to methyl aminolevulinate-mediated photodynamic therapy

    Article • Photodiagnosis and Photodynamic Therapy, December 2013, Elsevier

    Professor Monica Neagu

  16. Signal transduction molecule patterns indicating potential glioblastoma therapy approaches

    Article • OncoTargets and Therapy, November 2013, Taylor & Francis

    Professor Monica Neagu, Dr Ana-Maria Enciu

  17. Immunomics in Skin Cancer - Improvement in Diagnosis, Prognosis and Therapy Monitoring

    Article • Current Proteomics, October 2013, Bentham Science Publishers

    Professor Monica Neagu

  18. Therapy targets in glioblastoma and cancer stem cells: lessons from haematopoietic neoplasms

    Article • Journal of Cellular and Molecular Medicine, September 2013, Wiley

    Professor Monica Neagu

  19. Research Highlights: Highlights from the latest articles in biomarkers in medicine

    Article • Biomarkers in Medicine, April 2013, Future Medicine

    Professor Monica Neagu

  20. The C-terminal decapeptide of prothymosin α is responsible for its stimulatory effect on the functions of human neutrophils in vitro

    Article • International Immunopharmacology, January 2013, Elsevier

    Professor Monica Neagu

  21. Immune Parameters in The Prognosis and Therapy Monitoring of Cutaneous Melanoma Patients: Experience, Role, and Limitations

    Article • BioMed Research International, January 2013, Hindawi Publishing Corporation

    Professor Monica Neagu

  22. Whole Body Microwave Irradiation for Improved Dacarbazine Therapeutical Action in Cutaneous Melanoma Mouse Model

    Article • Radiology Research and Practice, January 2013, Hindawi Publishing Corporation

    Professor Monica Neagu

  23. Synthesis, photophysical and cytotoxicity evaluation of A3B type mesoporphyrinic compounds

    Article • Dyes and Pigments, November 2012, Elsevier

    Professor Monica Neagu

  24. 675 Signaling Molecules as Biomarkers in Brain Tumors

    Article • European Journal of Cancer, July 2012, Elsevier

    Professor Monica Neagu, Dr Ana-Maria Enciu

  25. Editorial [Hot Topic: Transcriptomic Biomarkers in Cancer Diagnosis, Prognosis and Therapy Monitoring (Guest Editor: Monica Neagu)]

    Article • Recent Patents on Biomarkerse, May 2012, Bentham Science Publishers

    Professor Monica Neagu

  26. Transcriptomics in Cancer - Stages Toward Patents in Biomarkers?

    Article • Recent Patents on Biomarkerse, May 2012, Bentham Science Publishers

    Professor Monica Neagu

  27. Research Highlights

    Article • Biomarkers in Medicine, April 2012, Future Medicine

    Professor Monica Neagu

  28. Immune-Therapy in Cutaneous Melanoma – Efficacy Immune Markers

    Article • February 2012, IntechOpen

    Professor Monica Neagu

  29. The Immune System—A Hidden Treasure for Biomarker Discovery in Cutaneous Melanoma

    Article • January 2012, Elsevier

    Professor Monica Neagu

  30. Potential intracellular tracker capacity of novel synthetic metalloporphyrins

    Article • Toxicology Letters, August 2011, Elsevier

    Professor Monica Neagu

  31. Application of 3D hydrogel microarrays in molecular diagnostics: advantages and limitations

    Article • Expert Review of Molecular Diagnostics, June 2011, Taylor & Francis

    Professor Monica Neagu

  32. P020. Soluble markers for prognostic and therapy monitoring of cutaneous melanoma

    Article • Melanoma Research, June 2011, Wolters Kluwer Health

    Professor Monica Neagu

  33. Patented Biomarker Panels in Early Detection of Cancer

    Article • Recent Patents on Biomarkers, March 2011, Bentham Science Publishers

    Professor Monica Neagu

  34. Sensitizer localization and immune response in photodynamic therapy of B16 cells

    Article • Laser Physics, February 2011, Pleiades Publishing Ltd

    Professor Monica Neagu

  35. Patented Biomarker Panels in Early Detection of Cancer

    Article • Recent Patents on Biomarkerse, January 2011, Bentham Science Publishers

    Professor Monica Neagu

  36. Tissular and soluble miRNAs for diagnostic and therapy improvement in digestive tract cancers

    Article • Expert Review of Molecular Diagnostics, January 2011, Taylor & Francis

    Professor Monica Neagu

  37. Immune-related biomarkers for diagnosis/prognosis and therapy monitoring of cutaneous melanoma

    Article • Expert Review of Molecular Diagnostics, October 2010, Taylor & Francis

    Professor Monica Neagu

  38. Nano-engineered materials based on fullerenes: synthesis and biomedical applications

    Article • September 2010, SPIE

    Professor Monica Neagu

  39. Porphyrin (TPP)–Polyvinylpyrrolidone (PVP)–Fullerene (C60) Triad as Novel Sensitizer in Photodynamic Therapy

    Article • Science of Advanced Materials, June 2010, American Scientific Publishers

    Professor Monica Neagu

  40. Microwave Synthesis, Basic Spectral and Biological Evaluation of Some Copper (II) Mesoporphyrinic Complexes

    Article • Molecules, May 2010, MDPI AG

    Professor Monica Neagu

  41. Fullerene–porphyrin nanostructures in photodynamic therapy

    Article • Nanomedicine, February 2010, Future Medicine

    Professor Monica Neagu

  42. Advances in Pancreatic Cancer Detection

    Article • January 2010, Elsevier

    Professor Monica Neagu

  43. Key signaling molecules in pituitary tumors

    Article • Expert Review of Molecular Diagnostics, November 2009, Taylor & Francis

    Professor Monica Neagu

  44. Investigation of the immunotoxic effects of some organophosphate pesticides in rats

    Article • Toxicology Letters, September 2009, Elsevier

    Professor Monica Neagu

  45. Research Highlights

    Article • Biomarkers in Medicine, August 2009, Future Medicine

    Professor Monica Neagu

  46. Biomarkers in the diagnosis and early detection of pancreatic cancer

    Article • Expert Opinion on Medical Diagnostics, July 2009, Informa Healthcare

    Professor Monica Neagu

  47. Biomarkers of metastatic melanoma

    Article • Biomarkers in Medicine, February 2009, Future Medicine

    Professor Monica Neagu

  48. Reactive Oxygen Species, Cancer and Anti-Cancer Therapies

    Article • Current Chemical Biology, January 2009, Bentham Science Publishers

    Professor Monica Neagu

  49. Reactive Oxygen Species, Cancer and Anti-Cancer Therapies

    Article • Current Chemical Biology, January 2009, Bentham Science Publishers

    Professor Monica Neagu

  50. Preliminary study on the immunologic background of good clinical outcome in rheumatoid arthritis patients after one month therapy with leflunomide

    Article • Rheumatology International, December 2008, Springer Science + Business Media

    Professor Monica Neagu

  51. In vitro evaluation of the anti-neoplastic action of novel nucleoside analogs

    Article • Toxicology Letters, October 2008, Elsevier

    Professor Monica Neagu

  52. Assessment of soluble angiogenic markers in pancreatic cancer

    Article • Biomarkers in Medicine, October 2008, Future Medicine

    Professor Monica Neagu

  53. Signaling profile pathways involved in pancreatic cancer progression

    Article • European Journal of Cancer Supplements, July 2008, Elsevier

    Professor Monica Neagu

  54. Radiation exposure facilities for medical studies in vitro and vivo

    Article • May 2008, Institute of Electrical & Electronics Engineers (IEEE)

    Professor Monica Neagu

  55. Immune disturbances in heroin addicts

    Article • Toxicology Letters, October 2007, Elsevier

    Professor Monica Neagu

  56. The effect of novel nucleoside analogues on normal and neoplastic immune cells

    Article • Toxicology Letters, October 2007, Elsevier

    Professor Monica Neagu

  57. Immunotoxic effects of some organophosphate pesticides in rats

    Article • Toxicology Letters, October 2007, Elsevier

    Professor Monica Neagu

  58. Immunotoxicology of mycotoxins produced by Fusarium fungi—Low concentrations of deoxynivalenol interfere with nucleotide metabolism

    Article • Toxicology Letters, October 2007, Elsevier

    Professor Monica Neagu

  59. Immunosuppressive action exerted in vitro by methotrexate-loaded liposomes

    Article • Toxicology Letters, October 2007, Elsevier

    Professor Monica Neagu

  60. Mechanisms in photodynamic therapy: photosensitizers and cellular localization on K562 cells

    Article • July 2007, SPIE

    Professor Monica Neagu

  61. Laser effect in photodynamic therapy of tumors

    Article • March 2007, SPIE

    Professor Monica Neagu

  62. Synthetic porphyrins in experimental photodynamic therapy induce a different antitumoral effect

    Article • Journal of Porphyrins and Phthalocyanines, January 2007, World Scientific Pub Co Pte Lt

    Professor Monica Neagu

  63. In vitro investigation of the immunotoxic effects exerted by organophosphorus compounds on lymphocyte proliferation

    Article • Toxicology Letters, September 2006, Elsevier

    Professor Monica Neagu

  64. In vitro effects of methadone on lymphocyte proliferation following a short-term treatment with methotrexate-loaded liposomes in a murine model of arthritis

    Article • Toxicology Letters, September 2006, Elsevier

    Professor Monica Neagu

  65. The immunologically active site of prothymosin α is located at the carboxy-terminus of the polypeptide. Evaluation of its in vitro effects in cancer patients

    Article • Cancer Immunology Immunotherapy, February 2006, Springer Science + Business Media

    Professor Monica Neagu, Evangelia Livaniou

  66. 442 Inhibition of pyrimidine synthesis by leflunomide modulates the oxidative activity of granulocytes in rheumatoid arthritis

    Article • Toxicology Letters, September 2003, Elsevier

    Professor Monica Neagu

  67. 543 Dose-dependent effects exerted in vitro by chlorpyrifos on the oxidative burst of human peripheral granulocytes

    Article • Toxicology Letters, September 2003, Elsevier

    Professor Monica Neagu

  68. 121 Biological markers monitoring Pb immunotoxicity; interference with ethanol

    Article • Toxicology Letters, September 2003, Elsevier

    Professor Monica Neagu

  69. 128 The in vitro functions of normal peripheral lymphocytes are influenced by low molecular weight heparines

    Article • Toxicology Letters, September 2003, Elsevier

    Professor Monica Neagu

  70. Plasma membrane potential interferes with the respiratory burst of peripheral granulocytes

    Article • Journal of Cellular and Molecular Medicine, January 2003, Wiley

    Professor Monica Neagu

  71. Imbalance of peripheral B lymphocytes and NK cells in rheumatoid arthritis

    Article • Journal of Cellular and Molecular Medicine, January 2003, Wiley

    Professor Monica Neagu

  72. Calcium ions modulate the respiratory burst of human polymorphonuclear cells

    Article • Immunology Letters, May 1997, Elsevier

    Professor Monica Neagu

  73. Calcium ions modulate the respiratory burst of human polymorphonuclear cells

    Article • Immunology Letters, May 1997, Elsevier

    Professor Monica Neagu

  74. Interference at the Respiratory Burst Level Between the Signals Delivered in vitro in Human Peripheral Neutrophils via fMLP, Complement and Fc Receptors

    Article • January 1997, Elsevier

    Professor Monica Neagu